Morgan Stanley
TDAC

Morgan Stanley’s Translational Development Acquisition Corp TDAC Stock Holding History

Morgan Stanley’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$824 Buy
78
+20
+34% +$211 ﹤0.01% 7463
2025
Q4 		$607 Buy
58
+46
+383% +$479 ﹤0.01% 7472
2025
Q3 		$124 Sell
12
-49
-80% -$506 ﹤0.01% 7648
2025
Q2 		$626 Sell
61
-3,021
-98% -$30.7K ﹤0.01% 7402
2025
Q1 		$31.1K Buy
+3,082
New +$31K ﹤0.01% 6426

Other funds holding TDAC

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Morgan Stanley's TDAC Position: Q1 2026 in Review

Morgan Stanley increased its Translational Development Acquisition Corp (TDAC) stake by 34% in Q1 2026, buying an estimated $211 and bringing the position to 78 shares worth $824. The position accounts for ﹤0.01% of the portfolio, ranked #7463.

Morgan Stanley first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $31.1K in Q1 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Morgan Stanley held 78 shares of Translational Development Acquisition Corp worth $824 as of Q1 2026.
  • Morgan Stanley bought 20 Translational Development Acquisition Corp shares in Q1 2026, an estimated $211.
  • Translational Development Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7463 holding.
  • Morgan Stanley first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Morgan Stanley's Translational Development Acquisition Corp position peaked at $31.1K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.